ストックスクリーナーアプリを入手
1.65
0.00%
0.00
Geron Corp (GERN) 最新ニュース
GERN Securities Lawsuit Filed Against Geron Corporation- Contact the DJS Law Group to Discuss Your Rights - PR Newswire
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)? - Yahoo Finance
GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit - Marketscreener.com
GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
GERN Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN)Contact Kessler Topaz Meltzer & Check, LLP - Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against XPLR, Geron, enCore, and TFI and Encourages Investors to Contact the Firm - TradingView
Deep Track Capital, LP's Strategic Acquisition of Geron Corp Shares - GuruFocus.com
Is Geron Corporation (NASDAQ:GERN) The Top Penny Stock That Will Skyrocket? - Yahoo Finance
Top 10 Penny Stocks That Will Skyrocket - Insider Monkey
GERN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GERN - GlobeNewswire Inc.
Class Action Filed Against Geron Corporation (GERN) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Eastern Progress Online
GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Indo-Asian News Service - IANS India Pvt Ltd
Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025GERN - PR Newswire
Geron Corporation Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 12, 2025 to Discuss Your RightsGERN - PR Newswire
Geron reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 19, 2025 at 04:43 pm EDT - Marketscreener.com
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Is Geron (GERN) Among the Most Oversold Penny Stocks to Buy According to Analysts? - Insider Monkey
Geron Corp: How Concerned Should We Be About Rytelo Sales? (NASDAQ:GERN) - Seeking Alpha
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron - Markets Insider
10 Most Oversold Penny Stocks to Buy According to Analysts - Insider Monkey
Rosen Law Firm Urges Geron Corporation (NASDAQ: GERN) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
GERN ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Geron Corporation Investors - TradingView
GERN INVESTOR ALERT: Geron Corporation Investors with Substantia - GuruFocus.com
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
HC Wainwright Reiterates Neutral Rating for Geron (NASDAQ:GERN) - Defense World
GERN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Investor Brings Securities Class Action Against Geron Corp. (1) - Bloomberg Tax
SBI Securities Co. Ltd. Acquires New Holdings in Geron Co. (NASDAQ:GERN) - Defense World
Geron’s SWOT analysis: biotech stock faces pivotal year for growth By Investing.com - Investing.com South Africa
Geron Corp appoints interim CEO amid leadership shuffle By Investing.com - Investing.com Australia
Geron Corp reveals CEO is leaving - The Pharma Letter
H.C. Wainwright holds neutral on Geron stock post-EU approval - Investing.com
H.C. Wainwright holds neutral on Geron stock post-EU approval By Investing.com - Investing.com South Africa
Geron’s SWOT analysis: biotech stock faces pivotal year for growth - Investing.com
Geron Co. (NASDAQ:GERN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Longtime Bay Area biotech CEO abruptly steps down - The Business Journals
Geron Announces Leadership Change with New Interim CEO - TipRanks
Geron Corp appoints interim CEO amid leadership shuffle - Investing.com India
Geron’s RYTELO gains EC approval for certain blood cancers - Investing.com
Geron announces EC approval of Rytelo - TipRanks
Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS - Yahoo Finance
Geron announces leadership transition, focuses on cancer drug potential - Investing.com
Geron CEO Scarlett to leave company - TipRanks
Geron Corporation Announces Departure Of CEO -March 11, 2025 at 04:03 pm EDT - Marketscreener.com
Geron Reshapes Leadership After FDA Win: CEO Exits as RYTELO Launch Takes Center Stage - StockTitan
Revolutionary Blood Cancer Drug RYTELO Wins European Approval: Geron's Game-Changing Treatment - StockTitan
Geron (NASDAQ:GERN) versus Dermata Therapeutics (NASDAQ:DRMA) Head-To-Head Comparison - Defense World
Insider Moves: Air Products, Inseego, Coterra, Geron, Green Thumb - TipRanks
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):